Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-13

Clinical Trial Update: Effects of GlucoClear CGM System on the Performance of Insulin Therapy in Critically Ill Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated how the GlucoClear CGM System affects insulin therapy in critically ill patients with metabolic stress hyperglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GlucoClear CGM System

Snippet

Sponsor: Erasme University Hospital | Conditions: Metabolic Stress Hyperglycemia | NA | Status: COMPLETED